EMEA-000781-PIP01-09

  • Email
  • Help

Overview

Product details for Nexavar
Invented nameNexavar
Active substance

Sorafenib (as tosylate)

Decision numberP/68/2010
PIP numberEMEA-000781-PIP01-09
Pharmaceutical form(s)Film-coated tablets
Condition(s)/indication(s)

Differentiated thyroid cancer

Route(s) of administrationOral use
PIP applicant

Applicant: Bayer Schering Pharma AG
E-mail: pediatrics.medical-affairs-europe@bayerhealthcare.com
Country: Germany
Phone: +49 3046815333
Fax: +49 3046815333

Decision typeW: decision granting a waiver in all age groups for the listed condition(s)

Decision